Amrutanjan Health Care Limited announced the outcome of its Board Meeting held on February 3, 2026. The Board approved the Unaudited Financial Results for the quarter and nine months ended December 31, 2025. The company reported a revenue from operations of ₹14,103.87 lakh for the quarter, an increase from ₹12,275.15 lakh in the same quarter last year. Profit after tax for the quarter stood at ₹1,945.22 lakh, compared to ₹1,924.57 lakh in the corresponding quarter of the previous year. Additionally, the Board declared a Second Interim Dividend of ₹1 per equity share for the financial year 2025-26. The company also noted its ESG rating of 68.6 from SES ESG Research Private Limited, which was independently prepared. The Board meeting commenced at 12:45 PM and concluded at 5:00 PM.
